Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Pharmacovigilance

UK regulator appeals to patients with animation about reporting drug side effects

Mick Foy, group manager for the MHRA’s vigilance and risk management of medicines division

Source: The Medicines and Healthcare products Regulatory Agency

Mick Foy says the campaign “will help the public, patients and healthcare professionals report potential side effects and have confidence that their reports are making a difference”

A short animation about the value of reporting drug side effects is being used as part of a social media campaign by the UK’s drug safety watchdog.

The Medicines and Healthcare products Regulatory Agency (MHRA), which regulates medicines and medical devices in the UK, hopes the animation, available on YouTube, will encourage patients to report side effects directly or to inform health professionals about the side effects they are experiencing so they can be officially recorded.

Mick Foy, group manager for the MHRA’s vigilance and risk management of medicines division, says: “Our campaign will help the public, patients and healthcare professionals report potential side effects and have confidence that their reports are making a difference.”

He says any suspected side effects can be reported easily and quickly through the MHRA’s Yellow Card scheme, either online or via a mobile app.

The MHRA campaign, which began on 7 November 2016 and will run until 11 November 2016, is part of the Europe-wide Strengthening Collaboration for Operating Pharmacovigilance in Europe (SCOPE) joint action project. The project is being supported by 22 EU member states.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2016.20201926

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Drugs of Abuse

    Drugs of Abuse

    A concise, easy-to-read guide for healthcare professionals who encounter drug abuse.

    £38.00Buy now
  • Sport and Exercise Medicine for Pharmacists

    Sport and Exercise Medicine for Pharmacists

    All the information you need to provide patients with evidence-based advice on sports and exercise related health matters.

    £27.00Buy now
  • Adverse Drug Reactions

    Adverse Drug Reactions

    A practical guide to the drug reactions that affect particular organ systems, and the management of these reactions.

    £38.00Buy now
  • English Delftware Drug Jars

    English Delftware Drug Jars

    This beautiful book illustrates the art and history of the collection of English delftware drug jars in the Museum of the Royal Pharmaceutical Society of Great Britain.

    £54.00Buy now
  • Paediatric Drug Handling

    Paediatric Drug Handling

    Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.

    £33.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Mick Foy, group manager for the MHRA’s vigilance and risk management of medicines division

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.